Within the last three months, Paul A. Mahon has sold $5,057,787.12 of United Therapeutics stock. Most recently, Paul A. Mahon sold 6,000 shares of the business's stock in a transaction on Thursday, September 22nd. The shares were sold at an average price of $203.34, for a transaction totalling $1,220,040.00. Following the completion of the sale, the executive vice president now directly owns 36,397 shares of the company's stock, valued at $7,400,965.98. Learn More on Paul A. Mahon's trading history.